Similar response to biologic therapy across racial and ethnic groups among patients with psoriasis enrolled in the CorEvitas Psoriasis Registry Letter

publication date

  • November 1, 2022

webpage

published in

keywords

  • QoL
  • biologic therapy
  • biologics
  • discontinu-ation
  • ethnicity
  • ethnoracial groups
  • outcomes
  • psoriasis
  • psoriatic disease
  • quality of life
  • race
  • switching
  • treatment response

start page

  • 1087

end page

  • 1089

volume

  • 87

issue

  • 5